Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity.
By Y. Chien, C. Scuoppo, Xiaowo Wang, X. Fang, B. Balgley, Jessica E. Bolden, P. Premsrirut, Weijun Luo, A. Chicas, C. S. Lee and 2 more. Genes & Development, 2011
978 citations recorded by the source corpus.
Cellular senescence acts as a potent barrier to tumorigenesis and contributes to the anti-tumor activity of certain chemotherapeutic agents. Senescent cells undergo a stable cell cycle arrest controlled by RB and p53 and, in addition, display a senescence-associated secretory phenotype (SASP) involving the production of factors that reinforce the senescence arrest, alter the microenvironment, and trigger immune surveillance of the senescent cells. Through a proteomics analysis of senescent chromatin, we identified the nuclear factor-κB (NF-κB) subunit p65 as a major transcription factor that accumulates on chromatin of senescent cells. We found that NF-κB acts as a master regulator of the SASP, influencing the expression of more genes than RB and p53 combined. In cultured fibroblasts, NF-κB suppression causes escape from immune recognition by natural killer (NK) cells and cooperates with p53 inactivation to bypass senescence. In a mouse lymphoma model, NF-κB inhibition bypasses treatment-induced senescence, producing drug resistance, early relapse, and reduced survival. Our results demonstrate that NF-κB controls both cell-autonomous and non-cell-autonomous aspects of the senescence program and identify a tumor-suppressive function of NF-κB that contributes to the outcome of cancer therapy.
Subfields: Cancer Research, Immunology, Physiology
View Paper: https://www.semanticscholar.org/paper/6dc1897ec48a6521984255282828603c81174912
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Immunology
In Physiology
- J. Campisi
- Jesús Gil
- Jiandong Chen
- V. Krizhanovsky
- Scott W. Lowe
- Domhnall McHugh
- Masashi Narita
- Mahito Sadaie
Citations in the corpus
- Cellular senescence and its effector programs (2014, background): “2008), and two transcription factors, NF-kB and C/EBPb, have been shown to be up-regulated, activated, and bound to chromatin during OIS and to cooperatively regulate the inflammatory components of the SASP (Acosta et al. 2008; Kuilman et al. 2008; Chien et al. 2011; Jing et al. 2011).”
- Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines (2018, background): “Both the redox-sensitive inflammatory pathway and the senescent cellrelated SASP activate the inflammasome through the NF-κB and IL-α cascade, causing persistence of the inflammatory response that delays resolution and healing (125, 138).”
- Aging, Cellular Senescence, and Cancer (2012, background): “The SASP cytokines that are responsible for these immune responses are incompletely understood but are very likely numerous (132, 135).”